| Literature DB >> 18818757 |
Saeko Imai1, Hana Kozai, Yuko Naruse, Kanji Watanabe, Michiaki Fukui, Goji Hasegawa, Hiroshi Obayashi, Naoto Nakamura, Yuji Naito, Toshikazu Yoshikawa, Shizuo Kajiyama.
Abstract
The aim of this study was to determine the effectiveness of education on diabetes prevention in subjects with impaired glucose tolerance. A total of 100 subjects of impaired glucose tolerance with hemoglobin A1c (HbA1c) levels >/=5.5 to <6.1% were assigned randomly to either support or control groups. All subjects received education in 8 sessions over a 6-month period. The support group consisted of 10 members collaborating with a dietitian or a nurse who learned coping skills by employing a participant-centered approach. Participants in the support group were required to keep a diary that monitored weight, food intake and blood glucose levels, while the control group attended several lectures. Subjects assigned to the support group had a reduction in mean HbA1c levels from 5.77 +/- 0.36% at baseline to 5.39 +/- 0.24% at the endpoint (p<0.01). Weight, total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and triglyceride (TG) levels also decreased (p<0.01) in the support group, whereas subjects in the control group had no observable reduction in these indices. After intervention, participants of the support group had improvements in their 2-h post-meal blood glucose levels. Support group education can be effective for improving glycemic control in participants when carried out in collaboration with educators and other team members.Entities:
Keywords: diabetes prevention; glycemic control; self-management education; support group
Year: 2008 PMID: 18818757 PMCID: PMC2533723 DOI: 10.3164/jcbn.2008050
Source DB: PubMed Journal: J Clin Biochem Nutr ISSN: 0912-0009 Impact factor: 3.114
Baseline characteristics of the two study groups
| Support group ( | Control group ( | ||
|---|---|---|---|
| Gender (male/female) | 9/41 | 8/42 | 0.790 |
| Age (years) | 63.2 ± 5.4 | 61.4 ± 4.8 | 0.074 |
| Weight (kg) | 57.0 ± 11.2 | 57.8 ± 10.6 | 0.914 |
| BMI (kg/m2) | 23.5 ± 3.4 | 24.1 ± 3.8 | 0.875 |
| HbA1c (%) | 5.78 ± 0.35 | 5.64 ± 0.44 | 0.075 |
| FBG (mg/dl) | 99 ± 9 | 100 ± 13 | 0.822 |
| TC (mg/dl) | 234 ± 30 | 232 ± 36 | 0.721 |
| LDL-C (mg/dl) | 143 ± 28 | 135 ± 32 | 0.172 |
| TG (mg/dl) | 142 ± 80 | 178 ± 137 | 0.116 |
| HDL-C (mg/dl) | 70 ± 19 | 63 ± 16 | 0.038 |
Data are expressed as either means ± SD or n.
Results of laboratory data at baseline and study endpoint in subjects in the two study groups
| Baseline ( | After 6-month ( | |
|---|---|---|
| HbA1c (%) | ||
| Support group | 5.77 ± 0.36 | 5.39 ± 0.24*† |
| Control group | 5.64 ± 0.45 | 5.73 ± 0.35 |
| FBG (mg/dl) | ||
| Support group | 100 ± 9 | 96 ± 10*† |
| Control group | 99 ± 13 | 107 ± 20 |
| TC (mg/dl) | ||
| Support group | 234 ± 29 | 220 ± 32* |
| Control group | 230 ± 37 | 221 ± 36 |
| LDL-C (mg/dl) | ||
| Support group | 143 ± 28 | 126 ± 28* |
| Control group | 131 ± 35 | 125 ± 31 |
| TG (mg/dl) | ||
| Support group | 144 ± 83 | 112 ± 53*† |
| Control group | 183 ± 139 | 169 ± 120 |
| HDL-C (mg/dl) | ||
| Support group | 70 ± 19 | 68 ± 16 |
| Control group | 62 ± 16 | 63 ± 16 |
Data are expressed as means ± SD. Baseline vs endpoint; * p<0.01.
Support group vs Control group at study endpoint; † p<0.01.